High-Concentration Cyanidin-3-O-Glucoside Attenuates Palmitic Acid-Induced Oxidative Stress via ROS Suppression in Pancreatic β-Cells
Journal of Experimental Pharmacology · 2026-05 · Volume 18 · 1-17
DOI: 10.2147/jep.s562755 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Pharmacology, 2026-05. Verfasst von Sasirin Chitwattananont und 2 weiteren Autor:innen. Beteiligte Einrichtung: Translational Medicine Graduate Program, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Background
Type 2 diabetes mellitus (T2DM) is characterized by progressive β-cell dysfunction driven in part by palmitic acid (PA)-induced lipotoxicity. Cyanidin-3-O-glucoside (C3G) possesses antioxidant properties, but its temporal and mechanistic effects at higher concentrations remain poorly defined.
Objective
This study aimed to investigate the continuous effects of high‑concentration of C3G on PA‑induced β‑cell apoptosis, with emphasis on time‑dependent efficacy and underlying antioxidant mechanisms.
Methods
MIN6 cells were treated with PA (500 μM) in the presence or absence of C3G (500 μM). Cell viability was assessed by MTT assay, apoptosis by flow cytometry and cell death assay, oxidative stress by DCFDA and DPPH assays, and ER-stress related C/EBP homologous protein (CHOP) and apoptotic cleaved caspase-3 expression by Western blot analysis.
Results
PA (500 μM) significantly reduced MIN6 cell viability, whereas continuous exposure to C3G (500 μM) restored viability, corresponding to a 40.9% increase (p < 0.001) compared with PA treatment alone. Flow cytometry showed that PA reduced live cells from 78.6% to 41.0% and increased early and late apoptotic populations to 27.7% and 28.2%, respectively, whereas C3G co-treatment reduced apoptosis to 17.7%. Consistently, cell death assays confirmed that C3G lowered apoptotic cells from 30.7% to 5.0% (p < 0.001 vs PA-treated groups) and restored viability to 93.1%, comparable to vehicle controls. Reactive oxygen species (ROS) assays, including DCFDA and DPPH, further demonstrated that C3G reduced PA‑induced ROS by 26.5% (p < 0.01 vs PA alone), consistent with free radical‑scavenging activity. Western blot analyses revealed that PA markedly upregulated CHOP and cleaved caspase‑3, which was suppressed by co‑treatment with C3G, confirming the attenuation by C3G of ER stress‑mediated apoptotic signaling. These findings imply that C3G rapidly counteracts oxidative stress-induced apoptosis.
Conclusion
High-concentration C3G mitigates PA-induced oxidative stress and ER stress-associated apoptosis in β-cells, supporting its potential as a therapeutic agent for T2DM. Plain Language Summary: Type 2 diabetes mellitus (T2DM) is a common metabolic disorder driven by progressive β-cell dysfunction, in which elevated free fatty acids, particularly palmitic acid (PA), induce oxidative stress-mediated apoptosis that accelerates disease progression. Cyanidin-3-O-glucoside (C3G) has been identified as a promising agent for protecting β-cells through its antioxidant capacity. This study aimed to investigate the protective role of high-concentration C3G against PA-induced β-cell apoptosis, focusing particularly on its efficacy in a dose- and time-dependent manner as well as the underlying antioxidant mechanism. We found that high concentrations of C3G mitigate PA-induced β-cell apoptosis by fully neutralizing reactive oxygen species (ROS) accumulation and downregulating ER stress-related apoptotic pathways. Altogether, our findings emphasized that high-concentration of C3G exerted a rapid and potent protective effect against oxidative stress-induced apoptosis, thereby highlighting its translational potential in the treatment of T2DM patients. Keywords: diabetes, oxidative stress, β-cells, palmitic acid, cyanidin-3-O-glucoside
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Translational Medicine Graduate Program, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
- Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Samutprakarn, Thailand.
ORCID-Profile: Chatchai Muanprasat
Zitieren
APA
Chitwattananont, S., Sawasvirojwong, S., & Muanprasat, C. (2026). High-Concentration Cyanidin-3-O-Glucoside Attenuates Palmitic Acid-Induced Oxidative Stress via ROS Suppression in Pancreatic β-Cells. Journal of Experimental Pharmacology, Volume 18, 1-17. https://doi.org/10.2147/jep.s562755
Vancouver
Chitwattananont S, Sawasvirojwong S, Muanprasat C. High-Concentration Cyanidin-3-O-Glucoside Attenuates Palmitic Acid-Induced Oxidative Stress via ROS Suppression in Pancreatic β-Cells. Journal of Experimental Pharmacology. 2026;Volume 18:1-17. doi:10.2147/jep.s562755
BibTeX
@article{Chitwattananont2026,
author = {Chitwattananont, Sasirin and Sawasvirojwong, Sutthipong and Muanprasat, Chatchai},
title = {High-Concentration Cyanidin-3-O-Glucoside Attenuates Palmitic Acid-Induced Oxidative Stress via ROS Suppression in Pancreatic β-Cells},
journal = {Journal of Experimental Pharmacology},
year = {2026},
volume = {Volume 18},
pages = {1--17},
doi = {10.2147/jep.s562755}
}
EUVIMED